Patents by Inventor Ashish Choudhary

Ashish Choudhary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIRNAS AS BIOMAKERS FOR DISTINGUISHING BENIGN FROM MALIGNANT THYROID NEOPLASMS
    Publication number: 20220213551
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as thyroid nodules or thyroid cancer, and using the profile in the diagnosis of a patient for a condition, such as thyroid nodules or thyroid cancer.
    Type: Application
    Filed: August 12, 2021
    Publication date: July 7, 2022
    Inventors: Sylvie Beaudenon-Huibregtse, Ashish Choudhary
  • miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms
    Patent number: 11118231
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as thyroid nodules or thyroid cancer, and using the profile in the diagnosis of a patient for a condition, such as thyroid nodules or thyroid cancer.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: September 14, 2021
    Assignee: INTERPACE DIAGNOSTICS, LLC
    Inventors: Sylvie Beaudenon-Huibregtse, Ashish Choudhary
  • MIRNAS AS BIOMARKERS FOR DISTINGUISHING BENIGN FROM MALIGNANT THYROID NEOPLASMS
    Publication number: 20190309370
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as thyroid nodules or thyroid cancer, and using the profile in the diagnosis of a patient for a condition, such as thyroid nodules or thyroid cancer.
    Type: Application
    Filed: November 13, 2018
    Publication date: October 10, 2019
    Inventors: Sylvie Beaudenon-Huibregtse, Ashish Choudhary
  • miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms
    Patent number: 10150999
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as thyroid nodules or thyroid cancer, and using the profile in the diagnosis of a patient for a condition, such as thyroid nodules or thyroid cancer.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: December 11, 2018
    Assignee: INTERPACE DIAGNOSTICS, LLC
    Inventors: Sylvie Beaudenon-Huibregtse, Ashish Choudhary
  • Comprehensive FMR1 genotyping
    Patent number: 9371560
    Abstract: Disclosed herein are methods for the automated reconstruction of a genotype of a gene, fragment, or genomic region using exhaustive enumeration. The methods can be used to reconstruct the genotype of any GC-rich sequence, such as the CGG repeat region in the 5? UTR of FMR1 or the CCG repeat region in the 5? UTR of FMR2. Also disclosed is an apparatus for use in conducting automated genotype reconstruction, as well as methods of diagnosis and treatment using exhaustive enumeration methods to reconstruct and identify genotypes associated with a disease or disorder.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: June 21, 2016
    Assignee: Asuragen, Inc.
    Inventors: Ashish Choudhary, Gary Latham, Sachin Sah
  • miRNA BIOMARKERS OF LUNG DISEASE
    Publication number: 20140274791
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Application
    Filed: April 11, 2014
    Publication date: September 18, 2014
    Applicant: Asuragen, Inc.
    Inventors: Elizabeth Mambo, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • MiRNA biomarkers of lung disease
    Patent number: 8735074
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: May 27, 2014
    Assignee: Asuragen, Inc.
    Inventors: Elizabeth Mambo, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary
  • COMPREHENSIVE FMR1 GENOTYPING
    Publication number: 20140024035
    Abstract: Disclosed herein are methods for the automated reconstruction of a genotype of a gene, fragment, or genomic region using exhaustive enumeration. The methods can be used to reconstruct the genotype of any GC-rich sequence, such as the CGG repeat region in the 5? UTR of FMR1 or the CCG repeat region in the 5? UTR of FMR2. Also disclosed is an apparatus for use in conducting automated genotype reconstruction, as well as methods of diagnosis and treatment using exhaustive enumeration methods to reconstruct and identify genotypes associated with a disease or disorder.
    Type: Application
    Filed: July 19, 2013
    Publication date: January 23, 2014
    Applicant: ASURAGEN, INC
    Inventors: Ashish Choudhary, Gary Latham, Sachin Sah
  • MIRNAS AS BIOMARKERS FOR DISTINGUISHING BENIGN FROM MALIGNANT THYROID NEOPLASMS
    Publication number: 20120157334
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as thyroid nodules or thyroid cancer, and using the profile in the diagnosis of a patient for a condition, such as thyroid nodules or thyroid cancer.
    Type: Application
    Filed: November 17, 2011
    Publication date: June 21, 2012
    Inventors: Sylvie Beaudenon-Huibregtse, Ashish Choudhary
  • MIRNA BIOMARKERS OF LUNG DISEASE
    Publication number: 20110053158
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.
    Type: Application
    Filed: August 27, 2010
    Publication date: March 3, 2011
    Applicant: Asuragen, Inc.
    Inventors: Elizabeth MAMBO, David Brown, Alex T. Adai, Tiffany Sanford, Stephanie Volz, Ashish Choudhary